What is barley sh-oligopeptide-1? Some facts you need to know
sh-oligopeptide-1 occurs naturally in the skin, but we can also synthesize sh-oligopeptide-1 in the lab using stem cells (called recombinant sh-oligopeptide-1). Some sh-oligopeptide-1 is produced using human stem cells. Chemists have discovered a method to synthesize it using genetically barley seed to create barley sh-oligopeptide-1.
It is reported that both regular sh-oligopeptide-1 and vegan Barley sh-oligopeptide-1 have been shown to be effective in reducing visible signs of aging and sun damage, and many pharmaceutical and cosmetic companies have turned their attention to this substance. The sh-oligopeptide-1 that can be found on the consumer market is usually an ingredient in topical skin care products or cosmetics, and some clinical treatments may require injections.
What is sh-Oligopeptide-1?
sh-Oligopeptide-1 is a single-chain recombinant human peptide produced by fermentation of E. coli. The starting gene synthesis is the same human gene that encodes epidermal growth factor. It contains up to 53 amino acids and may contain disulfide bonds and/or sugars. The protein is composed of the correct sequence of standard amino acids.
What is barley sh-oligopeptide-1?
Barley sh-oligopeptide-1 is a plant replica of sh-oligopeptide-1 that is bioengineered on barley plants using revolutionary science and technology, and then used as an active ingredient in skin care products.
There are many reasons to choose barley to produce sh-oligopeptide-1. The main reason is that barley has the ability to self-pollinate and barley is a closed organism and ecosystem, which helps green and safe product production.
Benefits of barley sh-oligopeptide-1
There are huge risks of toxins and contamination when growing sh-oligopeptide-1 in bacteria. There are ethical, moral and legal issues when extracting sh-oligopeptide-1 from human or animal cells. Plant-based sh-oligopeptide-1 replicas come from sustainable barley plants, which are pure, safe and effective, and their stability makes skin care effects outstanding.
Are there any downsides to using sh-oligopeptide-1 in skin care?
In most cases, complications or issues are relatively minor, but again, more research is needed. There is some evidence that sh-oligopeptide-1 may promote the growth of pre-existing cancerous tumors, but this is not conclusive; although sh-oligopeptide-1 itself may not cause cancer or produce tumors. There may be some concerns for people who are currently diagnosed or have a history of skin cancer, but in most cases, sh-oligopeptide-1 has been found to be safe.
There are reports that sh-oligopeptide-1 has difficulty penetrating deeply into the skin due to its larger molecular structure. But even with this challenge, many studies have shown a positive correlation between topical application of sh-oligopeptide-1 and visible effects of aging and sun damage. Still, more research is needed.
Looking for chemical products? Let suppliers reach out to you!
2026-07-14
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
IMM PE Plans to Partially Sell A’pieu Cosmetics Brand
-
Univar Solutions Expands Partnership with American Distilling in EMEA to Strengthen Natural Specialty Ingredients Distribution Network
-
IFF to Establish Scent Creative Center in Mumbai
-
Albéa Acquires Amfora Packaging, Strengthening Its Position in Latin America
-
BASF Builds New Alkyl Polyglucoside Plant in Thailand, Expands Its Business Footprint in Asia
-
Doré Partners with Evolved By Nature to Launch Two Breakthrough Skincare Products
-
COSMAX Acquires 51% Stake in Keminova, Establishes First European Production Base
-
Givaudan Breaks Ground on New Fragrance Factory in Guangzhou
-
Symrise Launches “Care & Wellness” Division to Strengthen Beauty–Health Integration
-
Retinol in Cosmetics: Regulatory Tightening and Market Changes
Recommend Reading
-
IMCD Opens Beauty and Personal Care Lab in California
-
Henkel to Acquire Olaplex in $1.4 Billion Deal
-
Givaudan to Build New Fragrance Compounding Facility in Pedro Escobedo, Mexico
-
End of an Era: KDC/One to Close 150-Year-Old Somerset Cosmetics Factory as Production Shifts to Scotland
-
DKSH to Distribute Exsymol's Silanols, Peptides, and Natural Active Ingredients in South Korea
-
Crude oil prices fall, retail prices of refined oil products in China continue to decrease
-
MTBE Market Prices Continue to Decline
-
Supply-demand contradiction difficult to alleviate, polyethylene remains weak
-
FDA Moves to Revoke 52 Outdated Food Standards Major Changes for Dairy, Canned Goods and Baked Products
-
2025 Cyclohexanone Market Review and 2026 Outlook in China